Sagamihara, Japan

Hideo Sobajima

This inventor holds 1 USPTO granted patent and 8 published patent applications. Top assignee: Olympus Corporation. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideo Sobajima. Retrieved from https://idiyas.com/inventor/hideo-sobajima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hideo Sobajima - Innovator in Treatment Devices

Hideo Sobajima is an inventor based in Hachioji-shi, Japan. He has made significant contributions to the field of medical technology, particularly in the development of treatment devices. His innovative approach focuses on applying energy to biological tissues for therapeutic purposes.

Latest Patent Applications: Hideo Sobajima's notable patent application is titled "TREATMENT DEVICE AND TREATMENT SYSTEM." This device is designed to apply energy to biological tissue to facilitate treatment. It features an interlocking mechanism that regulates the closing time and unit closing amount of the device's jaws. The mechanism interlocks the jaws with the operating body and includes an elastic member that maintains a constant load or pressure during operation. This innovative design aims to enhance the efficiency and effectiveness of treatment procedures.

Conclusion: Hideo Sobajima's work in developing treatment devices showcases his commitment to advancing medical technology. His innovative patent application reflects his dedication to improving therapeutic techniques for biological tissues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…